aTyr Pharma Inc
NASDAQ:ATYR

Watchlist Manager
aTyr Pharma Inc Logo
aTyr Pharma Inc
NASDAQ:ATYR
Watchlist
Price: 0.75 USD 6.67% Market Closed
Market Cap: 73.5m USD

Wall Street
Price Targets

ATYR Price Targets Summary
aTyr Pharma Inc

There are no price targets for ATYR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
aTyr Pharma Inc Competitors:
Price Targets
OXB
Oxford BioMedica PLC
30% Upside
ABNX
Abionyx Pharma SA
210% Upside
IMNM
Immunome Inc
22% Upside
002675
Yantai Dongcheng Biochemicals Co Ltd
31% Upside
NIOX
Niox Group PLC
24% Upside
9966
Alphamab Oncology
35% Downside
CPRX
Catalyst Pharmaceuticals Inc
48% Upside
BSLN
Basilea Pharmaceutica AG
51% Upside

Revenue
Forecast

Revenue Estimate
aTyr Pharma Inc

The compound annual growth rate of aTyr Pharma Inc's revenue for the next 4 years is 322%.

N/A
Past Growth
322%
Estimated Growth
Estimates Accuracy
20%
Average Beat

Operating Income
Forecast

Operating Income Estimate
aTyr Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Net Income
Forecast

Net Income Estimate
aTyr Pharma Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-95%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATYR's stock price target?
Not Available

ATYR doesn't have any price targets made by Wall Street professionals.

What is aTyr Pharma Inc's Revenue forecast?
Projected CAGR
322%

The compound annual growth rate of aTyr Pharma Inc's revenue for the next 4 years is 322%.

Back to Top